# Expression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate Cancer

> **NCT02723526** · — · UNKNOWN · sponsor: **Fudan University** · enrollment: 100 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** Blood drawing

## Key facts

- **NCT ID:** NCT02723526
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03
- **Primary completion:** 2019-03
- **Final completion:** 2019-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2016-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02723526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02723526, "Expression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02723526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*